Mar
27
Mon
CURE at Saint Joseph University Featuring: Susan Baserga – Resilience and Ribosomes: Practicing Persistence in Life and in the Lab @ University of Saint Joseph - Crystal Room, Mercy Hall, First floor.
Mar 27 @ 4:00 pm – 6:00 pm

CURE is pleased to collaborate with the University of Saint Joseph and with one of CT’s very talented scientists to discuss the delivery of excellence in research, administration, teaching and family. Light refreshments and opportunity for networking following Dr. Baserga’s seminar.

Host:

Susan Froshauer, Ph.D., President & CEO of CURE, President of CURE Innovations, LLC.

Susan is an experienced scientist, mentor, entrepreneur and angel investor with skill at connecting academic expertise and technology with the commercial sector. Susan is involved with the Yale Entrepreneurial Institute, the CTNEXT funded group, SECT Tech, the Creative Arts Workshop and the Angel Investor Forum. Prior to joining CURE, Dr. Froshauer was Director of the Technology Exchange Portal at the University of Connecticut’s Office of Economic Development. In this role Susan assisted Connecticut-based entrepreneurs and organizations with initiatives that train students, create jobs and contribute to economic development. She connected ideas with business expertise, business plans with investors and industry with scholars. Her passion and commitment is helping bioscience entrepreneurs build successful companies.

Speakers:

 

Susan Baserga, MD, Ph.D., Professor of Molecular Biophysics and Biochemistry, of Genetics and Therapeutic Radiology, Yale University

Susan Baserga received a B.S. in Biology from Yale College and an M.D. and Ph.D. (Human Genetics) from Yale in 1988.  She conducted post-doctoral training in the Department of Molecular Biophysics and Biochemistry at Yale with Joan Steitz.  Susan is currently an Associate Professor at Yale University with a primary appointment in Molecular Biophysics & Biochemistry and joint appointments in the Departments of Genetics and Therapeutic Radiology.  The focus of Susan’s research is on the function of ribonucleoproteins in pre-rRNA processing and pre-ribosome assembly.  Her research is principally funded by the National Institutes of Health and the National Science Foundation.

 

Melissa Marcucci, Ph.D., Associate Professor and Chair, Department of Biology, USJ

Serving as a tenured faculty member and Chair in the biology department at the University of Saint Joseph (USJ), Dr. Marcucci has provided students with a wide range of necessary tools to succeed in biology-based professions and STEM graduate programs.  She has shared her knowledge of biology in the classroom in a teaching and advisory capacity, as well as in the research laboratory.  Until becoming Chair, Dr. Marcucci maintained a research affiliation in the department of internal medicine at Yale University where she studied the molecular defects of insulin signaling in type 2 diabetes.  Dr. Marcucci also served as the Director of the CREC Summer Institutes for Science and Math for three summer, a collaboration with the Capitol Regions Education Council, to offer summer residence programs at USJ to select area high school students demonstrating academic excellence in STEM fields.  Currently, Dr. Marcucci currently serves as the Chair of the department of biology at USJ, a large complex department that is active in research and has a strong curriculum preparing students for professional careers in biomedical research, medicine, pharmaceutical sciences, and industry.  Aside from her passion for the biological sciences, Dr. Marcucci also advocates for leadership opportunities for women in science.

Directions and Parking:

 

Informational map showing the buildings and the exact location of talk on USJ campus: http://www.usj.edu/files/9514/7005/6952/campus_map.pdf

 

Refer to above map for parking at USJ:  best locations for parking are the large lots adjacent to the Center for Applied Research and Education (CARE) Building (#18 on map), visitors spots behind Mercy Hall (#1), and the large lot behind the Pope Pius XII Library (#12) (note that the numbers correspond to locations on the map)

 

Driving directions to USJ:  http://www.usj.edu/about-us/maps-directions/driving-direct/

 

SPONSORS:

    

 

 

Mar
28
Tue
BioHaven Presents: Biohaven Pharmaceuticals – Targeting Orphan Neurologic Indications and Other Neurological Pathways @ Anylan Center at Yale
Mar 28 @ 4:00 pm – 6:00 pm

Host:

Susan Froshauer, Ph.D., President & CEO of CURE, President of CURE Innovations, LLC

Susan is an experienced scientist, mentor, entrepreneur and angel investor with skill at connecting academic expertise and technology with the commercial sector. Susan is involved with the Yale Entrepreneurial Institute, the CTNEXT funded group, SECT Tech, the Creative Arts Workshop and the Angel Investor Forum. Prior to joining CURE, Dr. Froshauer was Director of the Technology Exchange Portal at the University of Connecticut’s Office of Economic Development. In this role Susan assisted Connecticut-based entrepreneurs and organizations with initiatives that train students, create jobs and contribute to economic development. She connected ideas with business expertise, business plans with investors and industry with scholars. Her passion and commitment is helping bioscience entrepreneurs build successful companies.

Speaker:

Vlad Coric, M.D.
Chief Executive Officer and Director, Biohaven Pharmaceuticals, Inc.

Dr. Coric has served as the chief executive officer and director of Biohaven since October 2015. Biohaven is a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological diseases, including rare disorders.  Dr. Coric has helped Biohaven raise over $100M since its inception, and investors include leading biotech funds such as Venrock, RA Capital Management, Vivo Capital, Aisling Capital, Rock Springs Capital, John W. Childs, Knoll Capital Management, Osage University Partners, Aperture Venture Partners, Connecticut Innovations, Greg Bailey and Litmore Capital.

Dr. Coric has more than 15 years of drug discovery and clinical development experience at Yale School of Medicine and Bristol-Myers Squibb. Within the pharmaceutical industry, Dr. Coric has expertise working across therapeutic areas including neuroscience, virology, oncology and immuno-oncology. Most recently, Dr. Coric was the immuno-oncology indication lead for neuro-oncology and glioblastoma. He has been involved in multiple drug development programs including marketed drugs such as ABILIFY® (aripiprazole; partial dopamine agonist), OPDIVO® (nivolumab; anti-PD1), YERVOY® (Ipilimumab; anti-CTLA-4), DAKLINZA® (daclatasvir; NS5A inhibitor) and SUNVEPRA® (asunaprevir; NS3 inhibitor). He has conducted numerous clinical trials in various illnesses including obsessive compulsive disorder, generalized anxiety disorder, major depression, schizophrenia, schizoaffective disorder, Alzheimer’s disease, hepatocellular carcinoma, and glioblastoma. Dr. Coric was the first to report the therapeutic effects of the glutamate-modulating agent riluzole in neuropsychiatric disorders (Coric et al., 2003; 2005; Sanacora et al., 2004) and led the first clinical trial employing cerebrospinal fluid biomarkers to identity and enrich for patients with Prodromal Alzheimer’s Disease while at Bristol-Myers Squibb (Coric et al 2015). Additionally, Dr. Coric spearheaded the design of and led the first global registrational trial using checkpoint inhibitors in glioblastoma. Dr. Coric is an Associate Clinical Professor of Psychiatry at the Yale School of Medicine and has over 50 peer-reviewed publications. He previously served as Chief of the Yale Clinical Neuroscience Research Unit, and Director of the Yale Obsessive-Compulsive Disorder Research Clinic. He has served as President of the Connecticut Psychiatric Society (an 800 member district branch of the American Psychiatric Association). Dr. Coric completed residency training at the Yale Psychiatry Residency Training Program, where he also served as the Program-Wide Chief Resident for the Yale Department of Psychiatry, and Chief Resident on the PTSD firm at the West-Haven Connecticut Veterans Administration Hospital. Dr. Coric earned his medical degree at Wake Forest University School of Medicine in North Carolina.

Sponsors:

 

 

Mar
29
Wed
2017 Women of Innovation® Finalists and Awards Gala @ Aqua Turf Club
Mar 29 @ 5:00 pm – 8:30 pm

Join us as we celebrate the Women of Innovation who make Connecticut’s businesses and institutions strong leaders on the cutting edge. The Women of Innovation® event seeks to create a growing network of women in the “trenches” of STEM. Our finalists are the scientists, researchers, academics, manufacturers, student leaders, drafters, entrepreneurs, and technicians who create tomorrow’s advancements through their tireless efforts today.

Join us

March 29, 2017
5:00 – 8:30 p.m.
the AquaTurf Club in Southington, CT

Register to attend today! We look forward to seeing you and your nominees on March 29!


Adda Birnir, CEO SkillcrushThe Connecticut Technology Council is excited to announce that our Keynote Speaker at the 2017 Women of Innovation® event will be Adda Birnir.

Adda is founder and CEO of Skillcrush, the country’s largest online education company focused on training women in technical topics, boasting an audience of over 250,000 women learning life-changing digital skills.

Before founding Skillcrush, Adda ran a web design and development company that built sites for media clients such as The New York Times, ProPublica, the Manhattan Neighborhood Network and MTV. She has been named one of the “20 Women to Watch in Media” by the Columbia Journalism Review, one of the “30 Most Important Women in Tech” by Business Insider, and has been featured on the BBC, PBS, Fast Company, and Mashable. She was recently appointed by Mayor Bill DeBlasio to the New York City Workforce Development board.

Adda is a graduate of Yale University and now calls New York City home. When not developing or teaching at Skillcrush, she enjoys exploring her home borough of Queens!

skillcrush logo

Skillcrush is the country’s largest online education company focused on training women in technical topics, boasting an audience of over 250,000 women actively learning life-changing digital skills. Their mission is simple: to empower their audience with the technical skills they need to enter high-earning and flexible careers. In particular, Skillcrush is focused on creating affordable and realistic on ramps into the technical fields for early to mid-career women who have no prior work or educational experience in computer science.


We are pleased to announce that Connecticut’s own Diane Smith will once again be Emcee for the evening’s festivities.

Diane Smith

Connecticut’s own Diane Smith will Emcee the 2017 Women of Innovation.

Register to attend today! We look forward to seeing you and your nominees on March 29!

Please note: nominations for the 2017 Women of Innovation® Awards are now closed. Stay tuned for our list of Finalists! 

Apr
19
Wed
Business of Biotech @ Various Locations
Apr 19 @ 3:00 am – 4:00 am

Business of Biotech is a workshop series that introduces grad students, postdocs and faculty from Yale and UConn to the core skills and building blocks to translate their research to the marketplace. This lecture and workshop series is designed to provide researchers in the life sciences with a comprehensive introduction to the bioscience business environment by exploring the process of transforming a scientific idea into a value­-generating product.

Presented by the Office of Cooperative Research and Yale Entrepreneurial Institute with support from the Yale Healthcare and Lifesciences Club, Canaan Partners, Wilson Sonsini Goodrich & Rosati, Jackson Labs and Alexion Pharmaceuticals.

*PLEASE NOTE THAT THESE OCCUR AT VARIOUS LOCATIONS AND CHECK INDIVIDUAL DATES FOR LOCATION INFO*

Schedule:

March 9, 5:30-7:30pm: “Drug Discovery A to Z: Go Ahead And Ask.” Join veteran drug discovery scientists from Charles River for a frank discussion about the drug discovery process.(at Brady Auditorium, 310 Cedar St.)

  • 5:30 pm – 6:15 pm: How Do We Prove a Drug Action is Selective?
    John Montana, PhD
    This talk will describe oversight of the drug discovery process within the pharma & biotech environment and focus on the importance of target engagement biomarkers and the role they can play from a translational efficacy and side effect liability perspective

    6:15 pm: All You Need to Know About Drug Development but Were Afraid to Ask (Q&A Round Table)
    Questions from the audience will drive a round table featuring a team of experienced drug discovery scientists from Charles River. This interactive session will touch on topics of interest from the audience regarding any aspect of drug discovery, from basic science through the out-licensing of projects and technologies.

April 19, 5:30-7:30pm: “Medical Devices/Diagnostics & Health IT” with Justin Chickles, CEO & Co-Founder, Mobile Sense Technologies, Inc.; Rosemary Harry, President, Device Foundations and Seth Feuerstein, Chief Medical Officer, Magellan Health (at Alexion, 100 College St., New Haven)

Business of Biotech @ Alexion Pharmaceuticals
Apr 19 @ 5:30 pm – 7:30 pm

Business of Biotech is a workshop series that will introduce grad students, postdocs and faculty from Yale and UConn to the core skills and building blocks to translate their research to the marketplace.

The series will launch Sept. 19-21 followed by monthly scheduled workshops, all hosted at Alexion. The series will bring in investors, biotech entrepre­neurs, legal experts and others to provide guidance, hands-on workshops and case studies on topics like business plans and funding for life science companies; intellectual property and regulatory considerations; marketing; case studies in life science entrepreneurship; FDA approval; trends in life science funding and exits and more.

Presented by the Office of Cooperative Research and Yale Entrepreneurial Institute with support from the Yale Healthcare and Lifesciences Club, Canaan Partners, Wilson Sonsini Goodrich & Rosati, Jackson Labs and Alexion Pharmaceuticals.

Schedule:

MON., SEPT. 19, 5:30-7:30pm: “Elements of a Business Plan and Sources of Capital for Early Stage Life Science Companies” with Colleen Cuffaro, Associate at Canaan Partners.Guest speakers for case studies include: Jason Hafler, Senior Director of Investments and Principal at Sanofi-Genzyme BioVentures; Susan Froshauer, President & CEO of Connecticut United for Research Excellence; Arthur Hiller, CEO of ENB Therapeutics and CEO of Antyllus Therapeutics, Inc; Lou Degennaro, President of Leukemia & Lymphoma Society.

TUES., SEPT. 20, 5:30-7:30pm: “Intellectual Property and Regulatory Considerations for Early Stage Life Science Companies” with Craig Kenesky, Associate Patent Attorney at WSGR. Guest speakers for case studies include: Erika Smith, Director of the Blavatnik Fund for Innovation at Yale; Cameron Pitt, Investment Professional at Versant Ventures and Associate at Highline Therapeutics; Angela Shen, CMO of Arvinas Inc.

WED., SEPT. 21, 5:30-7:30pm: “Marketing and Operations Considerations for Early Stage Life Science Companies” with Andrey Antov, Program Director of the Maine Cancer Genomics Initiative at The Jackson Laboratory. Guest speakers for case studies include:Daniel Wagner, Managing Director of Investments of Connecticut Innovations; Daniel Passeri, CEO of Context Pharma.

OTHER DATES:

October 19, 5:30-7:30pm: Case Studies in Life Science Entrepreneurship

November 16, 5:30-7:30pm: Tech Transfer – IP & Licensing

December 12, 5:30-7:30pm (Please note Monday!): FDA Approval and Regulatory Issues

January 25, 5:30-7:30pm: Trends in Life Science Funding & Exits, Corporate Strategy & Business Development

February 15, 5:30-7:30pm: Payors & Reimbursement

April 19, 5:30-7:30pm: Medical Devices/Diagnostics & Health IT

Apr
25
Tue
BioHaven Presents: Dr. John LaMattina – The Biopharmaceutical Industry’s Challenges in Drug Pricing @ The Anlyan Center at Yale
Apr 25 @ 4:00 pm – 6:00 pm

CURE is very pleased that Dr. LaMattina has agreed to return to our Biohaven series to discuss drug pricing transparency.   This discussion is suitable for the general public, legislators, students, faculty, and healthcare stakeholders.

Host:

Susan Froshauer, Ph.D., President & CEO of CURE, President of CURE Innovations, LLC

Susan is an experienced scientist, mentor, entrepreneur and angel investor with skill at connecting academic expertise and technology with the commercial sector. Susan is involved with the Yale Entrepreneurial Institute, the CTNEXT funded group, SECT Tech, the Creative Arts Workshop and the Angel Investor Forum. Prior to joining CURE, Dr. Froshauer was Director of the Technology Exchange Portal at the University of Connecticut’s Office of Economic Development. In this role Susan assisted Connecticut-based entrepreneurs and organizations with initiatives that train students, create jobs and contribute to economic development. She connected ideas with business expertise, business plans with investors and industry with scholars. Her passion and commitment is helping bioscience entrepreneurs build successful companies.

 

Speaker:

Dr. John LaMattina is the former Senior Vice President of Pfizer Inc. and former President of Pfizer Global Research and Development. In that role, Dr. LaMattina oversaw the drug discovery and development efforts of over 12,000 colleagues in the United States, Europe and Asia. During his tenure as head of global R&D, Pfizer produced new treatments for cancer, smoking cessation, rheumatoid arthritis and AIDS.

Dr. LaMattina is the author of numerous scientific publications and holds a number of U.S. patents. In addition, he is the author of “Drug Truths: Dispelling the Myths About Phama R&D” and “Devalued and Distrusted – Can the Pharmaceutical Industry Restore Its Broken Image?” He is also a contributor to Forbes.com.

He is currently a Senior Partner at PureTech Health and serves on the Board of Directors of Ligand Pharmaceuticals, Zafgen, Gelesis and Vedanta Biosciences.

 

Thank You to Our Sponsors:

 

Apr
27
Thu
StemConn 2017 @ Omni Hotel in New Haven, CT
Apr 27 @ 7:00 am – 5:00 pm

StemConn is Connecticut’s biannual premier conference on stem cell and regenerative medicine research. StemConn2017 will highlight cutting-edge research advancements in topics such as neuroscience, diabetes, epigenetics, myogenesis, liver regeneration, immunology and tissue engineering. Our program will also provide a forum for discussion among scientists, policy makers, and bioscience industry partners that will advance scientific knowledge and foster new collaborations. The conference will feature world-renowned speakers, networking and poster sessions, student meet-the-speaker opportunities, and a special Commercialization & Translation session featuring entrepreuners in CT. Come join us to celebrate the success and promise of Connecticut’s stem cell and regenerative medicine research!

Registration includes continental breakfast, boxed lunches, coffee breaks, all symposium talks, poster sessions and exhibits, and breakout sessions. Additional registration is required for the Symposium Breakfast Lecture and for the Meet-the-Speaker lunch breakouts (for postdocs and graduate students only).

For more information on the conference and program, please visit: stemconn.org

May
11
Thu
The CT Women’s Hall of Fame and CURE Innovation Commons STEMFems Event @ CURE Innovation Commons
May 11 all-day

More details to follow.

Jun
13
Tue
CURE Annual Meeting & The Annual Bioscience & Technology Community Picnic @ CURE Innovation Commons
Jun 13 @ 4:00 pm – 7:00 pm

Join us for The CURE Annual Meeting on June 13th from 4:00PM to 5:00PM and The Annual Bioscience & Technology Community Picnic at The Commons on June 13th from 5:00PM to 7:00PM. 

More details to follow.